Filing Details
- Accession Number:
- 0001127602-11-012904
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-12 19:32:36
- Reporting Period:
- 2011-04-11
- Filing Date:
- 2011-04-12
- Accepted Time:
- 2011-04-12 19:32:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190637 | F James Barlow | 2525 Dupont Drive Irvine CA 92612 | Sr. Vp, Corp. Controller (Pao) | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-04-11 | 351 | $75.09 | 11,798 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,495 | Indirect | By 401(k) Trust |
Common Stock | 639 | Indirect | By Esop Trust |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 7, 2011.
- Shares allocated to reporting person's SIP account as of reporting date.
- Shares allocated to the reporting person's ESOP account as of reporting date.